It is estimated that a large majority of tumors contain a disrupted or at least compromised P53 tumor-suppressive network [12] not only by mutation, but also by functional inactivation through MDMX and MDM4 overexpression or viral factors (e.g., HBX [46,56]) among other mechanisms. The gene discussed is TP53; the disease is neoplasm.